Mucormycosis

Pham D, Howard-Jones AR, Sparks R, et al. Epidemiology, modern diagnostics, and the management of mucorales infections. J Fungi (Basel). 2023 Jun 12;9(6):659.Full text  Abstract

Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005 Jul;18(3):556-69.Full text  Abstract

Centers for Disease Control and Prevention. Mucormycosis: clinical overview of mucormycosis. Apr 2024 [internet publication].Full text

Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019 Dec;19(12):e405-21.Full text  Abstract

1. Pham D, Howard-Jones AR, Sparks R, et al. Epidemiology, modern diagnostics, and the management of mucorales infections. J Fungi (Basel). 2023 Jun 12;9(6):659.Full text  Abstract

2. Steinbrink JM, Miceli MH. Mucormycosis. Infect Dis Clin North Am. 2021 Jun;35(2):435-52.Full text  Abstract

3. Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005 Jul;18(3):556-69.Full text  Abstract

4. Centers for Disease Control and Prevention. Mucormycosis: clinical overview of mucormycosis. Apr 2024 [internet publication].Full text

5. Vilela R, Mendoza L. Human Pathogenic Entomophthorales. Clin Microbiol Rev. 2018 Aug 29;31(4):e00014-18.Full text  Abstract

6. Walther G, Wagner L, Kurzai O. Updates on the taxonomy of mucorales with an emphasis on clinically important taxa. J Fungi (Basel). 2019 Nov 14;5(4):106.Full text  Abstract

7. Gonzalez CE, Rinaldi MG, Sugar AM. Zygomycosis. Infect Dis Clin North Am. 2002 Dec;16(4):895-914. Abstract

8. Centers for Disease Control and Prevention. Mucormycosis: data and statistics on mucormycosis. Apr 2024 [internet publication].Full text

9. Almyroudis NG, Sutton DA, Linden P, et al. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant. 2006 Oct;6(10):2365-74.Full text  Abstract

10. Benedict K, Jackson BR, Chiller T, et al. Estimation of direct healthcare costs of fungal diseases in the United States. Clin Infect Dis. 2019 May 17;68(11):1791-7.Full text  Abstract

11. Shaikh N, Hussain KA, Petraitiene R, et al. Entomophthoramycosis: a neglected tropical mycosis. Clin Microbiol Infect. 2016 Aug;22(8):688-94.Full text  Abstract

12. Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019 Dec;19(12):e405-21.Full text  Abstract

13. Lamoth F. Novel approaches in the management of mucormycosis. Curr Fungal Infect Rep. 2023 May 8:1-10.Full text  Abstract

14. Francis JR, Villanueva P, Bryant P, et al. Mucormycosis in children: review and recommendations for management. J Pediatric Infect Dis Soc. 2018 May 15;7(2):159-64.Full text  Abstract

15. Roilides E, Zaoutis TE, Walsh TJ. Invasive zygomycosis in neonates and children. Clin Microbiol Infect. 2009 Oct;15(suppl 5):50-4. Abstract

16. Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect. 2004 Mar;10(suppl 1):31-47.Full text  Abstract

17. Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and diagnosis of mucormycosis: an update. J Fungi (Basel). 2020 Nov 2;6(4):265.Full text  Abstract

18. Centers for Disease Control and Prevention. Mucormycosis risk factors. Apr 2024 [internet publication].Full text

19. Jordan A, James AE, Gold JAW, et al. Investigation of a prolonged and large outbreak of healthcare-associated mucormycosis cases in an Acute Care Hospital-Arkansas, June 2019-May 2021. Open Forum Infect Dis. 2022 Oct;9(10):ofac510.Full text  Abstract

20. Benedict K, Park BJ. Invasive fungal infections after natural disasters. Emerg Infect Dis. 2014 Mar;20(3):349-55.Full text  Abstract

21. Moorthy A, Gaikwad R, Krishna S, et al. SARS-CoV-2, uncontrolled diabetes and corticosteroids-an unholy trinity in invasive fungal infections of the maxillofacial region? A retrospective, multi-centric analysis. J Maxillofac Oral Surg. 2021 Mar 6;1-8.Full text  Abstract

22. John TM, Jacob CN, Kontoyiannis DP. When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis. J Fungi (Basel). 2021 Apr 15;7(4):2021 Apr 15;7(4):298.Full text  Abstract

23. Özbek L, Topçu U, Manay M, et al. COVID-19-associated mucormycosis: a systematic review and meta-analysis of 958 cases. Clin Microbiol Infect. 2023 Jun;29(6):722-31.Full text  Abstract

24. Kuehn BM. Cluster of mucormycosis cases linked with delta surge. JAMA. 2022 Feb 8;327(6):518.

25. Mejía-Santos H, Montoya S, Chacón-Fuentes R, et al. Notes from the field: mucormycosis cases during the COVID-19 pandemic - Honduras, May-September 2021. MMWR Morb Mortal Wkly Rep. 2021 Dec 17;70(50):1747-9.Full text  Abstract

26. Dulski TM, DeLong M, Garner K, et al. Notes from the field: COVID-19-associated mucormycosis - Arkansas, July-September 2021. MMWR Morb Mortal Wkly Rep. 2021 Dec 17;70(50):1750-1.Full text

27. Joshi S, Telang R, Tambe M, et al. Outbreak of mucormycosis in coronavirus disease patients, Pune, India. Emerg Infect Dis. 2022 Jan;28(1):1-8.Full text  Abstract

28. Lass-Flörl C. Zygomycosis: conventional laboratory diagnosis. Clin Microbiol Infect. 2009 Oct;15 Suppl 5:60-5.Full text  Abstract

29. Reyes HM, Tingle EJ, Fenves AZ, et al. Pulmonary invasive mucormycosis in a patient with secondary iron overload following deferoxamine therapy. Proc (Bayl Univ Med Cent). 2008 Oct;21(4):378-81.Full text  Abstract

30. Sharma A, Goel A. Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic. Folia Microbiol (Praha). 2022 Jun;67(3):363-87.Full text  Abstract

31. Suo T, Xu M, Xu Q. Clinical characteristics and mortality of mucormycosis in hematological malignancies: a retrospective study in Eastern China. Ann Clin Microbiol Antimicrob. 2024 Aug 29;23(1):82.Full text  Abstract

32. Cheok KPL, Farrow A, Springell D, et al. Mucormycosis after CD19 chimeric antigen receptor T-cell therapy: results of a US Food and Drug Administration adverse events reporting system analysis and a review of the literature. Lancet Infect Dis. 2024 Apr;24(4):e256-65. Abstract

33. Sahin B, Paydas S, Cosar E, et al. Role of granulocyte colony-stimulating factor in the treatment of mucormycosis. Eur J Clin Microbiol Infect Dis. 1996 Nov;15(11):866-9. Abstract

34. Sugar AM. Agents of mucormycosis and related species. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 6th ed. Philadelphia, PA: Churchill Livingstone; 2005:2973-81.

35. El Deeb Y, Al Soub H, Almaslamani M, et al. Post-traumatic cutaneous mucormycosis in an immunocompetent patient. Ann Saudi Med. 2005 Jul-Aug;25(4):343-5. Abstract

36. Addasi Y, Nguyen AH, Sabri A, et al. Gastrointestinal mucormycosis: a clinical review. Gastroenterology Res. 2023 Oct;16(5):249-53.Full text  Abstract

37. Elsiesy H, Saad M, Shorman M, et al. Invasive mucormycosis in a patient with liver cirrhosis: case report and review of the literature. Hepat Mon. 2013 Aug 11;13(8):e10858.Full text  Abstract

38. Gupta MK, Kumar N, Dhameja N, et al. Laboratory diagnosis of mucormycosis: present perspective. J Family Med Prim Care. 2022 May;11(5):1664-71.Full text  Abstract

39. Kontoyiannis DP, Lionakis MS, Lewis RE, et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis. 2005 Apr 15;191(8):1350-60.Full text  Abstract

40. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005 Sep 1;41(5):634-53.Full text  Abstract

41. Ledgard JP, van Hal S, Greenwood JE. Primary cutaneous zygomycosis in a burns patient: a review. J Burn Care Res. 2008 Mar-Apr;29(2):286-90. Abstract

42. Huang H, Xie L, Zheng Z, et al. Mucormycosis-induced upper gastrointestinal ulcer perforation in immunocompetent patients: a report of two cases. BMC Gastroenterol. 2021 Aug 3;21(1):311.Full text  Abstract

43. Alexander BD, Lamoth F, Heussel CP, et al. Guidance on imaging for invasive pulmonary aspergillosis and mucormycosis: from the imaging working group for the revision and update of the consensus definitions of fungal disease from the EORTC/MSGERC. Clin Infect Dis. 2021 Mar 12;72(suppl 2):S79-88.Full text  Abstract

44. McAdams HP, Rosado de Christenson M, Strollo DC, et al. Pulmonary mucormycosis: radiologic findings in 32 cases. AJR Am J Roentgenol. 1997 Jun;168(6):1541-8. Abstract

45. Skiada A, Lanternier F, Groll AH, et al. Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). Haematologica. 2013 Apr;98(4):492-504.Full text  Abstract

46. Kolekar JS. Rhinocerebral mucormycosis: a retrospective study. Indian J Otolaryngol Head Neck Surg. 2015 Mar;67(1):93-6.Full text  Abstract

47. Kontoyiannis DP, Lewis RE. Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Infect Dis Clin North Am. 2006 Sep;20(3):581-607. Abstract

48. Turunc T, Demiroglu YZ, Aliskan H, et al. Eleven cases of mucormycosis with atypical clinical manifestations in diabetic patients. Diabetes Res Clin Pract. 2008 Nov;82(2):203-8. Abstract

49. Gamba JL, Woodruff WW, Djang WT, et al. Craniofacial mucormycosis: assessment with CT. Radiology. 1986 Jul;160(1):207-12. Abstract

50. Glazier M, Nusair S, Breuer R, et al. The role of BAL in the diagnosis of pulmonary mucormycosis. Chest. 2000 Jan;117(1):279-82. Abstract

51. Lass-Florl C, Resch G, Nachbaur D, et al. The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients. Clin Infect Dis. 2007 Oct 1;45(7):e101-4.Full text  Abstract

52. Shahapure AG, Patankar RV, Bhatkhande R. Gastric mucormycosis. Indian J Gastroenterol. 2002 Nov-Dec;21(6):231-2. Abstract

53. Hammond SP, Bialek R, Milner DA, et al. Molecular methods to improve diagnosis and identification of mucormycosis. J Clin Microbiol. 2011 Jun;49(6):2151-3.Full text  Abstract

54. Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood. 1997 Aug 1;90(3):999-1008.Full text  Abstract

55. Spellberg B, Ibrahim AS. Recent advances in the treatment of mucormycosis. Curr Infect Dis Rep. 2010 Nov;12(6):423-9.Full text  Abstract

56. Arndt S, Aschendorff A, Echternach M, et al. Rhino-orbital-cerebral mucormycosis and aspergillosis: differential diagnosis and treatment. Eur Arch Otorhinolaryngol. 2009 Jan;266(1):71-6. Abstract

57. Dan M. Mucormycosis of the head and neck. Curr Infect Dis Rep. 2011 Apr;13(2):123-31. Abstract

58. Falci DR, Pasqualotto AC. Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections. Infect Drug Resist. 2013 Oct 22;6:163-74.Full text  Abstract

59. Enoch DA, Aliyu SH, Sule O, et al. Posaconazole for the treatment of mucormycosis. Int J Antimicrob Agents. 2011 Dec;38(6):465-73. Abstract

60. Andes D, Pascual A, Marchetti O. Antifungal therapeutic drug monitoring: established and emerging indications. Antimicrob Agents Chemother. 2009 Jan;53(1):24-34.Full text  Abstract

61. Lu B, Ha D, Shen S, et al. Combination antifungal therapy for invasive mucormycosis in immunocompromised hosts: a single-center experience. Open Forum Infect Dis. 2024 Jun;11(6):ofae103.Full text  Abstract

62. Smith C, Lee SC. Current treatments against mucormycosis and future directions. PLoS Pathog. 2022 Oct;18(10):e1010858.Full text  Abstract

63. Grimaldi D, Pradier O, Hotchkiss RS, et al. Nivolumab plus interferon-γ in the treatment of intractable mucormycosis. Lancet Infect Dis. 2017 Jan;17(1):18.Full text

64. Tawfik DM, Dereux C, Tremblay JA, et al. Interferon gamma as an immune modulating adjunct therapy for invasive mucormycosis after severe burn - a case report. Front Immunol. 2022 Aug 22;13:883638.Full text  Abstract

65. Ibrahim AS, Edwards JE Jr, Fu Y, et al. Deferiprone iron chelation as a novel therapy for experimental mucormycosis. J Antimicrob Chemother. 2006 Nov;58(5):1070-3.Full text  Abstract

66. Reed C, Bryant R, Ibrahim AS, et al. Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis. 2008 Aug 1;47(3):364-71.Full text  Abstract

67. Spellberg B, Walsh TJ, Kontoyiannis DP, et al. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis. 2009 Jun 15;48(12):1743-51.Full text  Abstract

68. Abidi MZ, Sohail MR, Cummins N, et al. Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphotericin combination therapies. Mycoses. 2014 Nov;57(11):687-98.Full text  Abstract

69. Kyvernitakis A, Torres HA, Jiang Y, et al. Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis. Clin Microbiol Infect. 2016 Sep;22(9):811.e1-8.Full text  Abstract

70. Glampedakis E, Roth R, Masouridi-Levrat S, et al. Real-life considerations on antifungal treatment combinations for the management of invasive mold infections after allogeneic cell transplantation. J Fungi (Basel). 2021 Sep 28;7(10):811.Full text  Abstract

71. Meena DS, Kumar D, Bohra GK. Combination therapy in mucormycosis: current evidence from the world literature, a mini review. J Mycol Med. 2023 Mar;33(1):101332.Full text  Abstract

72. Nattusamy L, Kalai U, Hadda V, et al. Bronchoscopic instillation of liposomal amphotericin B in management of nonresponding endobronchial mucormycosis. Lung India. 2017 Mar-Apr;34(2):208-9.Full text  Abstract

73. Alfageme I, Reina A, Gallego J, et al. Endobronchial instillations of amphotericin B: complementary treatment for pulmonary mucormycosis. J Bronchology Interv Pulmonol. 2009 Jul;16(3):214-5. Abstract

74. Anderson A, McManus D, Perreault S, et al. Combination liposomal amphotericin B, posaconazole and oral amphotericin B for treatment of gastrointestinal Mucorales in an immunocompromised patient. Med Mycol Case Rep. 2017 May 24;17:11-3.Full text  Abstract

75. Vashi N, Avedian R, Brown J, et al. Successful surgical and medical treatment of rhizopus osteomyelitis following hematopoietic cell transplantation. Orthopedics. 2012 Oct;35(10):e1556-61. Abstract

76. John BV, Chamilos G, Kontoyiannis DP. Hyperbaric oxygen as an adjunctive treatment for zygomycosis. Clin Microbiol Infect. 2005 Jul;11(7):515-7.Full text  Abstract

77. Page AV, Evans AJ, Snell L, et al. Primary cutaneous mucormycosis in a lung transplant recipient: case report and concise review of the literature. Transpl Infect Dis. 2008 Dec;10(6):419-25. Abstract

78. Lee FY, Mossad SB, Adal KA. Pulmonary mucormycosis: the last 30 years. Arch Intern Med. 1999 Jun 28;159(12):1301-9.Full text  Abstract

79. Simmons JH, Zeitler PS, Fenton LZ, et al. Rhinocerebral mucormycosis complicated by internal carotid artery thrombosis in a pediatric patient with type 1 diabetes mellitus: a case report and review of the literature. Pediatr Diabetes. 2005 Dec;6(4):234-8. Abstract

80. Koc Z, Koc F, Yerdelen D, et al. Rhino-orbital-cerebral mucormycosis with different cerebral involvements: infarct, hemorrhage, and ophthalmoplegia. Int J Neurosci. 2007 Dec;117(12):1677-90. Abstract